stockrow
Friday 6 November 2026
Export SERA’s income statement to Excel — free account
Sera Prognostics, Inc.
SERA Healthcare Medical Devices
Sera Prognostics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $81,000.00, up 5.19% from fiscal 2024.
- Revenue
- +162.5%
- EPS
- +0.88%
- Free cash flow
- −12.8%
Quarter to September 2026, against a year earlier
2.16
0.08
+3.85%
Follow SERA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | — | 3 | 3 |
| (51.83%) | (39.58%) | (45.03%) | (49.73%) | ||
| (36.59%) | (30.36%) | (33.47%) | (35.59%) | ||
ROIC |
(63.01%) | (113.18%) | (180.22%) | (278.58%) | |
Return on Tangible Assets |
(180.07%) | (117.29%) | (131.88%) | (142.94%) | |
Average Days of Receivables |
54.07 | 70.44 | 52.14 | 64.64 | |
Free Cash Flow per Share |
(0.55) | (0.55) | (0.57) | (0.58) | |
Free Cash Flow |
(26.35) | (27.57) | (28.53) | (29.37) | |
Capital Expenditures |
(0.73) | (0.73) | (0.85) | (0.87) | |
| Other line items | |||||
Cash ROIC |
(22.99%) | (23.97%) | (26.96%) | (30.43%) | |
Accounts Receivable Turnover |
3.52 | 3.17 | 5.19 | 6.19 | |
Accounts Payable Turnover |
0.12 | 0.17 | 0.16 | 0.18 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,918.48 | 1,686.48 | 2,482.00 | 2,178.77 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16,260.49% | 22,573.68% | 18,604.29% | 12,980.21% | |
Selling, General and Administrative Expense of Revenue |
28,703.70% | 41,470.18% | 34,528.57% | 25,671.88% | |
Share Based Compensation of Revenue |
6,308.64% | 7,810.53% | 5,615.71% | 4,122.92% | |
Interest Coverage |
(4,056.00) | (5,230.57) | (5,328.29) | (5,315.00) | |
Operating CF/Net income |
0.80 | 0.84 | 0.83 | 0.85 | |
Depreciation/Fixed assets |
0.82 | 0.84 | 0.61 | 0.48 | |
Capex/Depreciation |
(0.77) | (0.80) | (0.98) | (1.06) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.54) | (0.53) | (0.55) | (0.56) | |
Capex per Share |
(0.02) | (0.01) | (0.02) | (0.02) | |
Capex to Sales |
8.96 | 12.82 | 12.14 | 9.08 |
Columns are period end dates · fundamentals updated 6 Nov 2026